dc.creatorSAMPAIO-BARROS, Percival D.
dc.date.accessioned2012-10-19T23:40:44Z
dc.date.accessioned2018-07-04T15:20:18Z
dc.date.available2012-10-19T23:40:44Z
dc.date.available2018-07-04T15:20:18Z
dc.date.created2012-10-19T23:40:44Z
dc.date.issued2011
dc.identifierAMERICAN JOURNAL OF THE MEDICAL SCIENCES, v.341, n.4, p.287-288, 2011
dc.identifier0002-9629
dc.identifierhttp://producao.usp.br/handle/BDPI/25046
dc.identifier10.1097/MAJ.0b013e31820f8caf
dc.identifierhttp://dx.doi.org/10.1097/MAJ.0b013e31820f8caf
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1621772
dc.description.abstractDuring the period of 2006 to 2007, 28 university centers in Brazil used a standardized protocol of investigation to study the epidemiological, clinical and radiological variables of 1036 consecutive patients with the diagnosis of spondyloarthritis (SpA). Validated translated (Portuguese) versions of the Bath Ankylosing Spondylitis (AS) Disease Activity Index and the Bath AS Functional Index were applied. Patient diagnoses were predominantly AS (72.3%), followed by psoriatic arthritis (13.7%), undifferentiated SpA (6.3%), reactive arthritis (3.6%), juvenile SpA (3.1%) and arthritis related to inflammatory bowel disease (1.0%). There was a predominance of male (73.6%) and white (59.5%) patients. Pure axial disease was observed in 36.7% of the patients, whereas the mixed pattern (axial, peripheral and entheseal) was observed in 47.9%. The most common extra-articular involvement was anterior uveitis (20.2%). HLA-B27 was positive in 69.5% of the tested patients.
dc.languageeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relationAmerican Journal of the Medical Sciences
dc.rightsCopyright LIPPINCOTT WILLIAMS & WILKINS
dc.rightsrestrictedAccess
dc.subjectIberoamerica
dc.subjectBrazil
dc.subjectSpondyloarthritis
dc.subjectAnkylosing spondylitis
dc.subjectPsoriatic arthritis
dc.titleEpidemiology of Spondyloarthritis in Brazil
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución